Microbial regulation of hexokinase 2 links mitochondrial metabolism and cell death in colitis
J. Hamm, F. Hinrichsen, L. Schroder, N. Mishra, K. Shima, A. Walker, N. Sommer, K. Klischies, D. Prasse, J. Zimmermann, S. Kaiser, D. Bordoni, A. Fazio, G. Laue, V. Tremaroli, M. Basic, R. Hasler, R. A. Schmitz, S. Krautwald, A. Wolf, B. Stecher, P. Schmitt-Kopplin, C. Kaleta, J. Rupp, F. Backhed, , F. Sommer
Abstract
Hexokinases (HK) catalyze the first step of glycolysis and thereby limit its pace. HK2 is highly expressed in the gut epithelium, plays a role in immune responses and is upregulated in inflammation and ulcerative colitis 1-3. Here, we examined the microbial regulation of HK2 and its impact on intestinal inflammation by generating mice lacking HK2 specifically in intestinal epithelial cells (Hk2{Delta}IEC). Hk2{Delta}IEC mice were less susceptible to acute intestinal inflammation upon challenge with dextran sodium sulfate (DSS). Analyzing the epithelial transcriptome from Hk2{Delta}IEC mice during acute colitis revealed downregulation of cell death signaling and mitochondrial dysfunction dependent on loss of HK2. Using intestinal organoids derived from Hk2{Delta}IEC mice and Caco-2 cells lacking HK2, we identified peptidyl-prolyl cis-trans isomerase (PPIF) as a key target of HK2-mediated regulation of mitochondrial permeability and repression of cell-death during intestinal inflammation. The microbiota strongly regulated HK2 expression and activity. The microbially-derived short-chain fatty acid (SCFA) butyrate repressed HK2 expression and oral supplementation protected wildtype but not Hk2{Delta}IEC mice from DSS colitis. Our findings define a novel mechanism how butyrate may act as a protective factor for intestinal barrier homeostasis and suggest targeted HK2 inhibition as a promising therapeutic avenue in intestinal inflammation.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Hexokinase 2 expression in apical enterocytes correlates with inflammation severity in patients with inflammatory bowel disease
Saskia Weber‐Stiehl, Jan Taubenheim, … Felix Sommer·BMC MedicinePeer-reviewed·Oct 23, 2024
- Loss of HMGCS2-mediated intestinal stem cell ketogenesis is a metabolic barrier to mucosal healing in Ulcerative colitis
Duncan G. Rutherford, Verity E Cowell, … Gwo‐Tzer Ho·bioRxiv·Aug 25, 2025
- Inhibition of HtrA2 alleviated colitis by preventing necroptosis of intestinal epithelial cells
Chong Zhang, Andong He, … Jie Yan·Cell Death and DiseasePeer-reviewed·Apr 24, 2019
- KAT2 paralogs prevent dsRNA accumulation and interferon signaling to maintain intestinal stem cells
Mai-Uyen Nguyen, Sarah Potgieter, … Michael Paul Verzi·bioRxiv·Sep 4, 2023
- Deletion of epithelial HKDC1 decelerates cellular proliferation and impairs mitochondrial function of tumorous epithelial cells thereby protecting from intestinal carcinogenesis in mice
Lea Järke, Saskia Weber‐Stiehl, … Felix Sommer·癌症:英文版Peer-reviewed·Mar 20, 2025
- Goblet cell LRRC26 regulates BK channel activation and protects against colitis in mice
V. M. Gonzalez-Perez, P. L. Martinez-Espinosa, … C. J. Lingle·bioRxiv·Oct 23, 2020